We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Finch Therapeutics Group, Inc. (Finch) announced today the successful close of an oversubscribed $36 million Series B financing, bringing the total capital raised since the Company's launch to $77 million.